Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of ...

ENA101 is designed to selectively recognize the DARKFOX‑A3 peptide presented by HLA‑A*03:01, a highly prevalent HLA allele, ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

Dr. Premal Thaker reports IMNN-001 shows early survival benefit in ovarian cancer by activating immune response directly in ...

(This April 1 Health Rounds has been corrected to change ‘genetic’ to ‘genomic’ in the headline and the first item of the ...

SAN DIEGO -- Half of heavily pretreated patients with platinum-refractory ovarian cancer (PROC) responded to an ...

New Found Glory singer and guitarist Chad Gilbert, who has stage 4 cancer, tells PEOPLE that he is grateful for his family ...

First patient dosing occurred for JANX011 (NCT07291323), a CD19-targeted bispecific inaugurating the ARM platform to enable ...

While the safety was more manageable, questions remain about whether the combination would best antibody-drug conjugate ...

Based on positive phase 3 trial results, a New Drug Application will be submitted to the Food and Drug Administration for daraxonrasib.

This work, published in Nature Communications, opens new avenues for identifying tumors with a high risk of developing ...

Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...